Tirzepatide, Tirzepatide, Tirzepatide, Tirzepatide, Nisotirotide, placebo to match LY, Tirzepatide
J1R-MC-GZFD
Phase 2 small_molecule active
Quick answer
Tirzepatide, Tirzepatide, Tirzepatide, Tirzepatide, Nisotirotide, placebo to match LY, Tirzepatide for Type 2 Diabetes is a Phase 2 program (small_molecule) at Eli Lilly Co. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Eli Lilly Co.
- Indication
- Type 2 Diabetes
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active